Spyro Pharmaceuticals Private Limited
About Spyro Pharmaceuticals Private Limited
Data last updated:
Spyro Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the general merchandise retail segment of the home appliances and consumer durables sector. It was incorporated on 09 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U52100KA2021PTC145052.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sai Chand Yarra and Gopi Krishna Cheemaladinne.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #8 Ground Floor Anjanadri Nilaya Sanjeevani Nagara Mudalapalya, Bangalore, Karnataka, India – 560072.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.69 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹35,273 (net margin 1.5%) and EBITDA of ₹49,763 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 117% over three years.
Company details
Contact details
Spyro Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered Address#8 Ground Floor Anjanadri Nilaya Sanjeevani Nagara Mudalapalya, Bangalore, Karnataka, India – 560072
- IndustryHome Appliances, Non Specialized Stores, Retailers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spyro Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Spyro Pharmaceuticals Private Limited, buy the company report.
Financials of Spyro Pharmaceuticals Private Limited
FY 2025 filings availableSpyro Pharmaceuticals Private Limited reported revenue of ₹23.69 Lakh (up 270% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 117% over three years, including 270% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49,763 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,273 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spyro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spyro Pharmaceuticals Private Limited
Spyro Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sai Chand Yarra | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
| Gopi Krishna Cheemaladinne Also directs: Workbuddies Software Solutions Private Limited | Director | 09 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Spyro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spyro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Spyro Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Spyro Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Gopi Krishna Cheemaladinne was appointed as Director on 09 Mar 2021.
Frequently asked questions
Spyro Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in non specialized stores, within the home appliances industry. It was incorporated on 09 March 2021 (5+ years old) and is registered under CIN U52100KA2021PTC145052.
Spyro Pharmaceuticals has 2 current directors:
- Sai Chand Yarra - Director
- Gopi Krishna Cheemaladinne - Director
The latest financial statements of Spyro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Spyro Pharmaceuticals is U52100KA2021PTC145052. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spyro Pharmaceuticals was incorporated on 09 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Gopi Krishna Cheemaladinne was appointed as Director on 09 Mar 2021. Sai Chand Yarra was appointed as Director on 09 Mar 2021.
The registered office of Spyro Pharmaceuticals is at #8 Ground Floor Anjanadri Nilaya Sanjeevani Nagara Mudalapalya, Bangalore, Karnataka, India – 560072.
Spyro Pharmaceuticals operates in the home appliances industry, in the non specialized stores segment.
Spyro Pharmaceuticals can be reached at its registered office: #8 Ground Floor Anjanadri Nilaya Sanjeevani Nagara Mudalapalya, Bangalore, Karnataka, India – 560072.
Spyro Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
